Corporate Board Profile
Tech Score: 0/100
Filing Date | Source Excerpt |
---|---|
2015-05-06 | Dr. Charles S. Ryan joined the Board of Directors on August 10, 2011. Since March 2015, Dr. Ryan has been Vice President and General Counsel for Cold Spring Harbor Laboratory. The audit committee operates under a written charter approved by the Board of Directors. Messrs. Bitzer (Chairperson), Ryan and Shamash currently serve on the audit committee. The compensation committee is composed of John Bitzer, III, Yacov Shamash (Chairperson) and Charles Ryan. During the fiscal year ended September 30, 2014, we did not provide any cash compensation to our non-employee directors for their service on our Board of Directors. On November 30, 2011, the Board approved the recommendation from the Compensation Committee that each of the non-employee directors shall annually receive, for as long as they are a member of the Board, a 5-year stock option, fully vested after one year, to purchase a number of shares of common stock having a fair value of $60,000 as determined using the Black Scholes value, or as determined by the Compensation Committee. |
2016-04-21 | Dr. Charles S. Ryan joined the Board of Directors on August 10, 2011. Since March 2015, Dr. Ryan has been Vice President and General Counsel for Cold Spring Harbor Laboratory, a preeminent international research institution. Prior to that, Dr. Ryan was the Senior Vice President, and Chief Intellectual Property Counsel at Forest Laboratories, where he was employed from 2003 to 2014. Dr. Ryan has over 20 years’ experience in managing all aspects of intellectual property litigation, conducting due diligence investigations and prosecuting patent and trademark applications in the pharmaceutical and biotechnology industries. Dr. Ryan earned a doctorate in oral biology and pathology from SUNY Stony Brook and a law degree from Western New England College School of Law. Our Board believes that Mr. Ryan’s expertise as general counsel for a preeminent international research institution and former chief intellectual property counsel at a global company makes him an important contributor to the Board. |
2017-01-26 | Dr. Charles S. Ryan joined the Board of Directors on August 10, 2011. Since October 2016, he has been Chief Executive Officer of Orthobond, Inc. From March 2015 until October 2016, Dr. Ryan was Vice President and General Counsel for Cold Spring Harbor Laboratory, a preeminent international research institution. Prior to that, Dr. Ryan was the Senior Vice President, and Chief Intellectual Property Counsel at Forest Laboratories, where he was employed from 2003 to 2014. Dr. Ryan has over 20 years’ experience in managing all aspects of intellectual property litigation, conducting due diligence investigations and prosecuting patent and trademark applications in the pharmaceutical and biotechnology industries. Dr. Ryan earned a doctorate in oral biology and pathology from SUNY Stony Brook and a law degree from Western New England College School of Law. Our Board believes that Dr. Ryan’s expertise as Chief Executive Officer for a medical device company, as well as general counsel for a preeminent international research institution and former chief intellectual property counsel at a global company makes him an important contributor to the Board. The audit committee held five formal meetings during fiscal 2016. |
2018-01-16 | Dr. Charles S. Ryan joined the Board of Directors on August 10, 2011... The audit committee of the Board of Directors (the “audit committee”) operates under a written charter approved by the Board of Directors... THE AUDIT COMMITTEE John Bitzer, III (Chairperson) Charles Ryan Yacov Shamash |
2019-04-04 | Dr. Charles S. Ryan joined the Board of Directors on August 10, 2011. ... Dr. Ryan has over 20 years’ experience in managing all aspects of intellectual property litigation ... Our Board believes that Dr. Ryan’s expertise as Chief Executive Officer for a medical device company, as well as general counsel for a preeminent international research institution and former chief intellectual property counsel at a global company makes him an important contributor to the Board. ... Compensation Committee ... Messrs. Bitzer, Ceccoli, and Shamash (Chairperson) served on the compensation committee during the fiscal year ended September 30, 2018. ... Director Compensation: Fiscal 2018 ... Charles S. Ryan ... Option Awards ($) 81,304 ... Total ($) 81,304. |
2019-10-08 | Charles S. Ryan |
Data sourced from SEC filings. Last updated: 2025-08-30